YTHDF2 may have a role in glioblastoma adaptation to the tumour microenvironment, facilitating the maintenance of GSCs in the hypoxic niche [92] and contributing to temozolomide resistance [90,95]. This evidence concerns the gene YTHDF2 and neoplasm.